跳至主要内容
临床试验/NCT02249468
NCT02249468终止不适用

An Exploratory Study to Compare the Differences in Nutritional Status Between Patients With Mild and Moderate Alzheimer's Disease (AD) and Cognitively Intact Healthy People in an Asian Population

Danone Nutricia Research1 个研究点 分布在 1 个国家目标入组 191 人开始时间: 2014年10月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
191
试验地点
1
主要终点
Serum Phospholipids and Fatty Acid Profile

研究概览

简要总结

Difference in nutritional status between patients with mild and moderate Alzheimer's Disease (AD) and cognitively intact healthy people in an Asian population

详细描述

The main objective of the current Asian nutritional status study is to get more insight into the nutritional status of AD patients in an Asian population in Asia. Plasma levels of several micronutrients and the fatty acid profile will be compared between patients with mild and moderate AD and cognitively intact healthy controls in an Asian population

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 50 years old
  • Asian ethnicity
  • Group 1: Cognitively intact healthy volunteers defined by Cumulative Illness Rating Scale for Geriatrics rating of ≤ 2 for all categories except for the category "psychiatric illness" which should have a rating of 0 and a CDR of 0 within 1 year prior to the visit.
  • Group 2a: AD patients clinically diagnosed with mild AD (according to the National Institute of Neurological and Communicative Disorders, and Stroke-Alzheimer's Disease and Related Disorders criteria (McKhann et al., 1984)) with Clinical Dementia Rating-1
  • Group 2b: AD patients clinically diagnosed with moderate AD (according to the National Institute of Neurological and Communicative Disorders, and Stroke-Alzheimer's Disease and Related Disorders criteria (McKhann et al., 1984)) with Clinical Dementia Rating-2
  • Written informed consent provided according to local regulations.

排除标准

  • Group 1 only: Current diagnosis of AD or other dementias according to National Institute of Neurological and Communicative Disorders, and Stroke-Alzheimer's Disease and Related Disorders criteria (McKhann et al.,1984 )
  • Group 2 only: Change in dose within 2 months prior to visit of AD medication (e.g. donepezil, rivastigmine, galantamine or memantine)
  • Group 1 and 2:
  • Diagnosis of significant neurological disease (for Groups 2a and 2b: other than AD), including vascular dementia according to National Institute of Neurological and Communicative Disorders, and Stroke-Alzheimer's Disease and Related Disorders criteria, cerebral tumour, Huntington's Disease, Parkinson's Disease, normal pressure hydrocephalus, seizures, major depression, schizophrenia and other entities
  • Use of vitamins supplements (only vitamins supplements C and D are allowed) for 3 months prior to the visit
  • Use of vitamin B injections
  • Alcohol or drug abuse as per investigator's judgement
  • Investigator's uncertainty about the willingness or ability of the patient to comply with the protocol requirements
  • Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study

结局指标

主要结局

Serum Phospholipids and Fatty Acid Profile

时间窗: 1 day

Serum Phospholipids, fatty acid profile e.g. docosahexaenoic acid / eicosapentaenoic acid / phosphatidylcholine docosahexaenoic acid To look at nutritional Status in the blood

Uridine

时间窗: 1 day

To look at nutritional Status in the blood

Homocysteine

时间窗: 1 day

To look at nutritional Status in the blood

Vitamin E

时间窗: 1 day

To look at nutritional Status in the blood

Plasma polar lipid profile

时间窗: 1 day

Plasma polar lipid profile including several types of phospholipids and their specific species; and cholesterol-esters To look at nutritional Status in the blood

Red Blood Cell Phospholipids and fatty acid profile

时间窗: 1 day

Red Blood Cell Phospholipids, fatty acid profile e.g. docosahexaenoic acid / eicosapentaenoic acid / phosphatidylcholine docosahexaenoic acid To look at nutritional Status in the blood

Choline

时间窗: 1 day

To look at nutritional Status in the blood

Kidney function - Creatinine

时间窗: 1 day

Other blood parameters

Vitamin B12

时间窗: 1 day

To look at nutritional Status in the blood

Inflammatory marker

时间窗: 1 day

C-reactive protein analysed using high sensitive C-reactive protein

Vitamin B6

时间窗: 1 day

To look at nutritional Status in the blood

Folate

时间窗: 1 day

To look at nutritional Status in the blood

Selenium

时间窗: 1 day

To look at nutritional Status in the blood

Vitamin D

时间窗: 1 day

To look at nutritional Status in the blood

HbA1C (haemoglobin A1C )

时间窗: 1 day

Other blood parameters

Liver Function - Alanine Aminotransferase and Aspartate Aminotransferase

时间窗: 1 day

Other blood parameters

次要结局

未报告次要终点

研究者

发起方
Danone Nutricia Research
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验